Implant Detects Opioid Overdose and Automatically Administers Naloxone
The implantable device, tested in animal models, continuously monitors vital signs and automatically administers naloxone during opioid overdose.
The implantable device, tested in animal models, continuously monitors vital signs and automatically administers naloxone during opioid overdose.
Researchers from Brigham and Women's Hospital and Harvard Medical School estimate the number of childhood TB cases is double previous estimates: about 1 million annually with 32,000 suffering from multidrug-resistant TB.